In our previous study, we have shown a trend towards worse disease-free survival in breast tumours with weak and strong DO-1 staining (p53 antibody capable of detecting all isoforms retaining the transactivation domain, TAp53, and used as a surrogate for full-length p53 detection) compared to moderate levels [64]. Here, TP53 is linked to breast neoplasm.